Neptune Technologies & Bioresources Increases Sales but Misses Estimates on Earnings
Neptune Technologies & Bioresources (NAS: NEPT) reported earnings on July 16. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended May 31 (Q1), Neptune Technologies & Bioresources beat expectations on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue increased significantly and GAAP loss per share dropped.
Gross margins improved, operating margins dropped, net margins expanded.
Neptune Technologies & Bioresources booked revenue of $5.9 million. The one analyst polled by S&P Capital IQ wanted to see revenue of $5.8 million on the same basis. GAAP reported sales were 34% higher than the prior-year quarter's $4.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at -$0.02. The one earnings estimate compiled by S&P Capital IQ predicted $0.00 per share. GAAP EPS were -$0.02 for Q1 compared to -$0.03 per share for the prior-year quarter.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 58.7%, 680 basis points better than the prior-year quarter. Operating margin was -27.6%, 510 basis points worse than the prior-year quarter. Net margin was -16.0%, 360 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $6.2 million. On the bottom line, the average EPS estimate is -$0.01.
Next year's average estimate for revenue is $26.9 million. The average EPS estimate is -$0.02.
The stock has a one-star rating (out of five) at Motley Fool CAPS, with 26 members rating the stock outperform and 145 members rating it underperform. Among 94 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), three give Neptune Technologies & Bioresources a green thumbs-up, and 91 give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Neptune Technologies & Bioresources is outperform, with an average price target of $7.27.
Over the decades, small-cap stocks, like Neptune Technologies & Bioresources have provided market-beating returns, provided they're value priced and have solid businesses. Read about a pair of companies with a lock on their markets in "Too Small to Fail: Two Small Caps the Government Won't Let Go Broke." Click here for instant access to this free report.
- Add Neptune Technologies & Bioresources to My Watchlist.
The article Neptune Technologies & Bioresources Increases Sales but Misses Estimates on Earnings originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.